Creo Medical says first patients successfully treated with new medical device

Writer, Stock Market Wire
Wednesday, January 16, 2019 - 13:51

Creo Medical Group said the first patients had been successfully treated in the US using its 'Speedboat' medical device.

The device enabled the removal of cancerous and pre-cancerous gastrointestinal growths.

It used an electrosurgical generator that combined bipolar radiofrequency for precise, localised cutting and microwave for controlled coagulation.

Two surgeons from the same hospital were trained in the use of the device over the weekend and successfully used it on the patients this week.

Creo said it expected to increase the number of trained clinicians in the US as the roll-out of a company education programme continued.

At 1:51pm: (LON:CREO) Creo Medical Group Plc share price was +14p at 226p

Related content

Creo Medical gets first order for gastrointestinal devices

Medical device company Creo Medical Group said it had received its first commercial orders for a range of gastrointestinal devices.

The so-called Speedboat device was...

Tue, 25/06/2019 - 14:55

Creo Medical Group losses double as costs of rolling out new technology soars

Creo Medical Group losses more than doubled in the 18 months through December last year amid soaring costs as the company ramped up clinical and...

Fri, 05/04/2019 - 09:27

Creo Medical announces first use of Speedboat in mainland Europe

Creo Medical Group announced Monday that the Hospital Universitario Virgin del Rocio de Sevilla had treated the first patient in mainland Europe using the company's...

Mon, 03/12/2018 - 09:32

Creo Medical signs Benelux, Spain distribution agreements

Medical device Group Creo Medical said Wednesday it had signed two distribution agreements to provide clinical training and market seeding across Spain, Belgium, the Netherlands...

Wed, 17/10/2018 - 10:03

Creo Medical extends distribution agreement with Pentax

Medical device group Creo Medical said Monday it had tweaked its distribution agreement with Hoya Group, Pentax Medical, extending the term of the latter's distribution...

Mon, 17/09/2018 - 07:44